HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis.

Abstract
Parkinsonism with evidence of midbrain dysfunction has been reported in a few patients with aqueductal stenosis after placement of ventriculoperitoneal (VP) shunt. The response to levodopa is variable. We report a patient with neurocysticercosis of the fourth ventricle who developed transient parkinsonism without evidence of midbrain dysfunction after placement of a VP shunt. The frequency of tremor was 5-5.5 Hz. Though the response to levodopa was initially slow, later it was significant, and after 3 months he was asymptomatic without levodopa. The exact pathophysiology of parkinsonism in our patient remained obscure.
AuthorsD K Prashantha, M Netravathi, S Ravishankar, Samhita Panda, Pramod Kumar Pal
JournalClinical neurology and neurosurgery (Clin Neurol Neurosurg) Vol. 110 Issue 7 Pg. 718-21 (Jul 2008) ISSN: 0303-8467 [Print] Netherlands
PMID18440127 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiparkinson Agents
  • Levodopa
Topics
  • Adult
  • Antiparkinson Agents (therapeutic use)
  • Cerebral Ventricles (pathology)
  • Humans
  • Hydrocephalus (etiology, pathology)
  • Levodopa (therapeutic use)
  • Male
  • Neurocysticercosis (complications, diagnosis)
  • Parkinsonian Disorders (drug therapy, etiology, pathology)
  • Ventriculoperitoneal Shunt (adverse effects, methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: